$0.69
▲ +1.0% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Overview
52-week range
$0.53
$2.35
9% of range
Avg surprise (last 3)
-1.1%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
967%
EM ±197.9% · $1 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.20 | — | — | — | — | financials |
| Wed May 6, 2026 | Mar/2026 | $-0.09 | $-0.09 | 0.0% | +62.5% | +4.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.12 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.14 | $-0.20 | +30.0% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.24 | $-0.18 | -33.3% | — | -3.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.30 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.34 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.40 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.39 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.45 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.43 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $225,000 | — | — | $0 | $0 | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-44M | $-20M | — | $-21M | $-24M | $-28M | — | $-27M |
| Net income | $-43M | $-19M | — | $-20M | $-23M | $-27M | — | $-26M |
| EPS (diluted) | $-0.20 | $-0.09 | — | $-0.12 | $-0.14 | $-0.24 | — | $-0.30 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $78M | $81M | $101M | $56M | $63M | $54M | $4M | $8M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $86M | $97M | $106M | $61M | $76M | $94M | $67M | $85M |
| Total assets | $94M | $135M | $147M | $105M | $122M | $144M | $120M | $141M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $24M | $29M | $24M | $22M | $22M | $25M | $27M | $28M |
| Total equity | $69M | $106M | $123M | $83M | $100M | $119M | $93M | $113M |